Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1668 News Items found Cycle for Survival Passes $260 Million Wednesday, April 1, 2020 Now in its 14th year, Cycle for Survival has raised more than $260 million for research on rare cancers. Harnessing the Power of Data for Patient Care Wednesday, April 1, 2020 Computational biology is helping to bring predictive power and precision to oncology. Infectious Disease Specialist Mini Kamboj Discusses COVID-19 Wednesday, April 1, 2020 Infectious disease expert Mini Kamboj shares what people with cancer should know about COVID-19 and how MSK is keeping our patients and staff safe MSK Enters a New Era with Opening of the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center Wednesday, April 1, 2020 Open to patients in January 2020, the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center provides nearly every aspect of cancer care under one roof. The Big Break: Maria Jasin and the Discovery That Launched Gene Editing Wednesday, April 1, 2020 More than 20 years ago, this SKI scientist laid the groundwork for a field that is now transforming medicine. Winter Lunch Raises Funds for Pediatric Cancer Research Wednesday, April 1, 2020 Learn about how The Society of Memorial Sloan Kettering is supporting precision medicine at MSK Kids. In the Lab Drug Combination Could Boost the Effectiveness of Immunotherapy against Pancreatic Cancer Tuesday, March 31, 2020 Studies conducted in mice reveal a potential way to breach the defenses of pancreatic cancer tumors. Q&A MSK Women in Science: Marissa Gredler Friday, March 27, 2020 Get to know Marissa Gredler, a postdoctoral fellow in the Sloan Kettering Institute. Q&A MSK Women of Science: Ana Silveira Thursday, March 26, 2020 Get to know Ana Silveira, a computational biology postdoctoral fellow in the Sloan Kettering Institute. In the Clinic Back-to-Back Studies Support the Use of HER2-Targeted Therapies in Multiple Cancers Wednesday, March 25, 2020 Results from a clinical trial and animal studies provide support for targeting the HER2 protein in multiple cancer types. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next MSK Experts Present Research at Bone Marrow Transplant and Cellular Therapy Meeting